US · Healthcare

Biomea Fusion Inc (BMEA)

Biotechnology

Biomea Fusion Inc (BMEA) is listed on US in the Healthcare sector. Industry: Biotechnology. As of 2026-05-23, reported P/E ratio is 25.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for BMEA

P/E ratio

25.00

Biomea Fusion Inc (BMEA) — FAQ

What is BMEA's P/E ratio?

The price-to-earnings (P/E) ratio for Biomea Fusion Inc (BMEA) is 25.00 (data as of 2026-05-23).

Does Biomea Fusion Inc pay a dividend?

Dividend yield is not available in the current snapshot for Biomea Fusion Inc (BMEA). Check the MyAverix Finance app for the latest dividend data.

What sector is Biomea Fusion Inc in?

Biomea Fusion Inc (BMEA) is classified in the Healthcare sector (Biotechnology industry).

What exchange is BMEA listed on?

BMEA is listed on US.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)